BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8509998)

  • 1. Losartan prevents salt-induced hypertension in reduced renal mass rats.
    Kanagy NL; Fink GD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1131-6. PubMed ID: 8509998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
    Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
    von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
    J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
    Soltis EE
    J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telemetric blood pressure monitoring in benign 2-kidney, 1-clip renovascular hypertension: effect of chronic caffeine ingestion.
    Kost CK; Li P; Pfeifer CA; Jackson EK
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1063-70. PubMed ID: 7932154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A; Henegar JR; Devineni VR; Janicki JS
    Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 17. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats.
    Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.